1.
Acta Pharmaceutica Sinica B
; (6): 1541-1554, 2021.
Artigo
em Inglês
| WPRIM (Pacífico Ocidental)
| ID: wpr-888819
RESUMO
Obesity and its associated complications are highly related to a current public health crisis around the world. A growing body of evidence has indicated that G-protein coupled bile acid (BA) receptor TGR5 (also known as Gpbar-1) is a potential drug target to treat obesity and associated metabolic disorders. We have identified notoginsenoside Ft1 (Ft1) from